Benefits of Propolis

Evidence-Based Benefits

• Cold prevention — an RCT by Cohen et al. (2004) found that children given propolis extract during winter had significantly fewer upper respiratory infections and shorter illness duration compared to placebo, with 55% fewer episodes of acute otitis media
• Antimicrobial activity — propolis flavonoids and CAPE demonstrate activity against Staphylococcus aureus, Streptococcus mutans, E. coli, Candida albicans, and influenza virus, likely through cell membrane disruption and enzyme inhibition
• Anti-inflammatory — CAPE is one of the most potent natural NF-kB inhibitors identified, suppressing inflammatory cascades that drive excessive immune responses, tissue damage, and chronic inflammation
• Upper respiratory support — propolis throat sprays deliver antimicrobial and anti-inflammatory compounds directly to the pharyngeal mucosa, reducing sore throat severity and supporting local immune defense
• Immune modulation — propolis enhances macrophage activation, increases antibody production (particularly secretory IgA), and modulates T-cell balance, supporting a coordinated immune response

What the Research Says

Propolis has a growing clinical evidence base. Cohen et al. (2004) conducted a well-designed RCT showing propolis significantly reduced upper respiratory infections in children during winter. Sforcin (2007) published a comprehensive review of propolis's biological properties, confirming its antimicrobial spectrum against bacteria, viruses, fungi, and parasites, plus its anti-inflammatory and immunomodulatory effects. CAPE has emerged as a particularly interesting compound, with potent NF-kB inhibition that has attracted attention from cancer researchers as well. The main challenge in propolis research is standardization — propolis composition varies by geographic origin, bee species, and plant sources, making comparison across studies difficult. Brazilian green propolis and European poplar-type propolis are the most studied varieties.

Related Conditions